Status Epilepticus Management

Status epilepticus is one of the true neurological emergencies, and USMLE Step 1 tests whether you know both its definition and its management sequence. The classic trap is using the old 30-minute definition — the operational threshold that actually triggers treatment is ≥5 minutes of continuous seizure activity (or two discrete seizures without return to baseline in between). If a vignette shows a patient still seizing at 5 minutes, treatment should already be underway. Students who hold onto the 30-minute number will hesitate on management timing questions and pick the wrong answer.

The exam tests this as a stepwise pharmacologic ladder, and the order matters. Benzodiazepines are always first — lorazepam IV is the classic choice in the hospital, midazolam IM if no IV access, diazepam rectal in the field. If the seizure continues, you escalate to second-line agents: phenytoin or fosphenytoin IV (fosphenytoin is preferred because it's less caustic). The common misconception is reaching for phenytoin first — it's not first-line, and picking it in that slot is a high-yield wrong answer that Step 1 actively exploits.

The third tier — refractory status epilepticus — is where most students have a knowledge gap entirely. If benzodiazepines and a second-line agent both fail, the answer is continuous anesthetic infusion (propofol, midazolam drip, or pentobarbital) with continuous EEG monitoring. This is tested less frequently but appears in harder vignettes. Knowing all three tiers cold, in order, is what separates strong performance on USMLE Step 1 from guessing at the margins.